A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still rapidly spreading worldwide. Many drugs and vaccines have been approved for clinical use show efficacy in the treatment and prevention of SARS-CoV-2 infections. However, the emergence of SARS-CoV-2 variants of concern (VO...

Descrición completa

Detalles Bibliográficos

Principais autores:	Xinghai Zhang, Huajun Zhang, Tingting Li, Shaohong Chen, Feiyang Luo, Junhui Zhou, Peiyi Zheng, Shuyi Song, Yan Wu, Tengchuan Jin, Ni Tang, Aishun Jin, Chengyong Yang, Guofeng Cheng, Rui Gong, Sandra Chiu, Ailong Huang
Formato:	Artigo
Idioma:	Inglês
Publicado:	Nature Publishing Group 2022-08-01
Series:	Signal Transduction and Targeted Therapy
Acceso en liña:	https://doi.org/10.1038/s41392-022-01135-3
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!